RE: 18% spread, what that meanns for those that are unaware6 Nov 2025 14:37
But as mentioned yesterday it is a false spread for typical transactions The true spread is much smaller, around 0.40-0.42, so absolutely normal for AIM
PYC are exploring the development of new dosing tools beyond Docetaxel and G-CSF with DosemeRx. Pete Sargent mentioned at the recent IMC presentation that they would be 'sure to provide further feedback and announcements as we progress the expanded partnership'
PYC must have a good idea as to how a dosing tool commercial agreement would look. Jim did mention in March that PYC should be able to provide some metrics as to the potential size of the market for the tool in the US at some stage
'The Department for Science, Innovation and Technology has today (Thursday 30 October) confirmed long-term R&D funding for the UK’s research agencies and bodies, with bumper investment for the bodies that are making science and tech breakthroughs that improve lives and grow our economy'
Trout, if you are unhappy then sell up here (as you said you would a while back) and put the extra into FAB. Speak to PS directly if you are genuinely interested and have unanswered questions
PYC is a decent well-respected company with potential on numerous fronts. The share price has traded in the 0.40-0.50 range for months. I believe it will break out permanently once material news on its various collaborations is released
Not too long ago the CEO of Beyond Blood highlighted an article on specialist grants available in the sector on his LinkedIn account (article link no longer visible). I think it could have been this one :-